Purpose: Patients who undergo growth-friendly (GF) treatment for early-onset scoliosis (EOS) undergo multiple clinical and surgical encounters. We sought to quantify the associated temporal and travel burden and estimate subsequent cost.
Methods: Four centers in an international study group combined data on EOS patients who underwent surgical GF treatment from 2006 to 2021.